# the Integrated Traditional Chinese and Western Medicine Treat Middle Stage DKD

> **NCT03681249** · EARLY_PHASE1 · COMPLETED · sponsor: **Shanghai University of Traditional Chinese Medicine** · enrollment: 112 (actual)

## Conditions studied

- Diabetic Nephropathy Type 2

## Interventions

- **DRUG:** ShenqiDihuang Decoction
- **DRUG:** ShenqiDihuang Decoction placebo

## Key facts

- **NCT ID:** NCT03681249
- **Lead sponsor:** Shanghai University of Traditional Chinese Medicine
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-02
- **Primary completion:** 2021-12-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 112 (ACTUAL)
- **Last updated:** 2022-05-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03681249

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03681249, "the Integrated Traditional Chinese and Western Medicine Treat Middle Stage DKD". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03681249. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*